Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CuraGen (CRGN) -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (86)	2/23/1999 9:13:00 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 478

CuraGen Corporation Announces Fourth Quarter And Year End 1998 Financial Results A $44 Million Stock Offering and Glaxo Wellcome Collaboration Highlight Year biz.yahoo.com For the fourth quarter, the Company reported a net loss attributable to common stockholders of $8,250,270, or $0.62 per share, Seems to me that is quite a bit more than expected, twenty cents worse in fact based on estimate on Yahoo, but in the race for SNPs maybe spending more and spending it fast is actually better. Spindoctoring ...I should probably waited a few more days before scoring my shares...probably could have saved myself a buck a share.